Coronavirus LIVE Updates: US FDA Gives Nod to Booster Dose of Pfzier-BioNTech Covid-19 Vaccine for 65 Plus, High-Risk Adults
Coronavirus Updates: The Pfizer booster shots will be administered to those aged 65 and adults at high risk, they will be inoculated at least six months after completion of the primary series.